Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
OS Therapies Inc has filed 218 SEC EDGAR filings since 05 Dec 2019

SEC filing history

Showing 101-125 of 218 matching filings.

Per page
25
Current page
5
DEF 14A File 001-42195

PROXY STATEMENT

Filing date
28 Feb 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

3/A filing

Filing date
26 Feb 2025
Reporting date
31 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Feb 2025
Reporting date
14 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284631

EFFECT filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94604

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-42195

PROXY STATEMENT

Filing date
07 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
06 Feb 2025
Reporting date
28 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284631

UPLOAD filing

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-284631

REGISTRATION STATEMENT

Filing date
31 Jan 2025
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-42195

CURRENT REPORT

Filing date
29 Jan 2025
Reporting date
28 Jan 2025
Next action
Verify source filing
D File 021-535849

D filing

Filing date
22 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-94604

SCHEDULE 13D filing

Filing date
17 Jan 2025
Reporting date
Not listed
Next action
Verify source filing
4

4 filing

Filing date
17 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .